Sequencing Platform of Strasbourg GenomEast
Introduction
The GenomEast Platform is hosted at the IGBMC (CNRS / University of Strasbourg / INSERM). With an experience of over 20 years, we offer a wide range of services to survey genomes, their expression and their regulation, from advice on experimental design and quality check of starting material up to data analysis. These services are intended for the entire scientific community, national and international, public and private.
Expertise
- Transcriptome analysis: RNA-seq (using various protocols adapted to different quality and quantity of starting material and to different aims of the studies), single-cell/nucleus RNA-seq (from fresh or fixed cells), spatial transcriptomics.
- Epigenome analysis: ChIP-seq, Cut&Run, MeDIP-seq, single cell ATAC-seq, sequencing of ATAC-seq or Cut&Tag libraries.
- Genome analysis: targeted regions (exome, regions of interest), whole genome sequencing.
- Multiome analysis: single cell ATAC + gene expression.
Over the past years, we have gained a strong expertise in single cell sequencing technologies (Research Expertise 2021 prize from the University of Strasbourg). We further implement new applications each year.
In collaboration with the histology department at the Institut Clinique de la Souris, we have established a comprehensive spatial transcriptomics service leveraging two leading technologies: Visium (10x Genomics) and GeoMx Digital Spatial Profiler (NanoString/Bruker). Our team provides guidance to users in designing their experiments and selecting the most appropriate technology. We then manage the entire workflow – from FFPE or OCT blocks, or histological sections, through to sample processing, data acquisition, and analysis. Always eager to explore new approaches, we are open to the use of other technologies. For instance, we have evaluated the Curio Seeker technology (Curio Biosciences) on frozen sections.
Equipments
- High-throughput sequencing: NextSeq2000 and iSeq100 (Illumina), AVITI (Element Biosciences)
- High-throughput nanofluidics: Chromium X (10X Genomics)
- Spatial transcriptomics: Visium CytAssist (10X Genomics), GeoMx Digital Spatial Profiler (NanoString/Bruker)
- Quality control: Qubit Fluorometer (Thermo Fisher), 2100 Bioanalyzer and AATI Fragment Analyzer (Agilent)
- Sonicator: E220 AFA system (Covaris)
- IT Infrastructure: computing power (Dell): 304 cores, storage (Lenovo, GPFS): 750 TB
Bioinformatics
Personalized support for data analysis (RNA-seq, single cell RNA-seq and ATAC-seq, ChIP-seq, Cut&Run, Cut&Tag, ATAC-seq, MEDIP-seq, DNA-seq, spatial transcriptomics), from primary analysis to a large panel of in-depth secondary analysis through scientific collaborations. In particular, we have established analyses pipelines using publicly available tools or in-house software.
Regular organization of training sessions on Next Generation Sequencing data analysis.

Main achievements
Over the past three years, the platform worked each year on about 250 projects (corresponding each year to about 3,000 sequenced libraries), and the bioinformaticians from the platform analysed each year about 150 projects.
Members of the platform are co-authors of 52 publications over the last three years. A selection is listed below:
- Cai Q, Sahu R, Ueberschlag-Pitiot V, Souali-Crespo S, Charvet C, Silem I, Cottard F, Ye T, Taleb F, Metzger E, Schuele R, Billas IML, Laverny G, Metzger D, Duteil D. LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice. Nature Communications. 2024 ; 15(1):3563.
- Bertacchi M, Maharaux G, Loubat A, Jung M, Studer M. FGF8-mediated gene regulation affects regional identity in human cerebral organoids. Elife. 2024 ; 13:e98096.
- Dupré N, Gueniot F, Domenga-Denier V, Dubosclard V, Nilles C, Hill-Eubanks D, Morgenthaler-Roth C, Nelson MT, Keime C, Danglot L, Joutel A. Protein aggregates containing wild-type and mutant NOTCH3 are major drivers of arterial pathology in CADASIL. The Journal of Clinical Investigation. 2024 ;134(8):e175789.
- Davidson G, Helleux A, Vano YA, Lindner V, Fattori A, Cerciat M, Elaidi RT, Verkarre V, Sun CM, Chevreau C, Bennamoun M, Lang H, Tricard T, Fridman WH, Sautes-Fridman C, Su X, Plassard D, Keime C, Thibault-Carpentier C, Barthélémy P, Oudard SM, Davidson I, Malouf GG. Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear-cell renal cell carcinoma. Cancer Research, 2023;83(17):2952-2969.
- Terzic J, Abu el Maaty M, Lutzing R, Vincent A, El Bizri R, Jung M, Keime C, Metzger D. Hypoxia-inducible factor 1A inhibition overcomes castration resistance of prostate tumors. EMBO Molecular Medicine, 2023;15(6):e17209.
- Scutenaire J, Plassard D, Matelot M, Villa T, Zumsteg J, Libri D, Séraphin B. The S. cerevisiae m6A-reader Pho92 promotes timely meiotic recombination by controlling key methylated transcripts. Nucleic Acids Research. 2023 ; 51(2):517-535.
- Ramos-Alonso L, Holland P, Le Gras S, Zhao X, Jost B, Bjørås M, Barral Y, Enserink JM, Chymkowitch P. Mitotic chromosome condensation resets chromatin to safeguard transcriptional homeostasis during interphase. PNAS. 2023 ; 120(4):e2210593120.
Last update Jan 2025

Quality Certification/ Label/Partnership
The platform is ISO 9001 certified since January 2007 and NFX 50-900 since January 2016.
IBiSA platform since 2008.
Partner of the French Foundation for rare diseases (Fondation Maladies Rares) since 2011.

Platform Managment
Scientific Committee :
Gilles Laverny, Gérard Gradwohl and Amélie Piton
Technical coordinator :
Christelle Thibault-Carpentier
GenomEast platform
IGBMC UMR 7104 CNRS-Univertité de Strasbourg / INSERM U1258
1, rue Laurent Fries,
67404 ILLKIRCH Cedex, France
Contacts
Christelle Thibault Carpentier
thibault@igbmc.fr